Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05604508 · ClinicalTrials.gov registry record · NA
Testing Legally Feasible Options Studies 2/3
A NA study, sponsored by RAND.
- Completed
- Registry status
- NA
- Development phase
- 445
- Enrollment target
NCT05604508: Completed NA study, sponsored by RAND.
NCT05604508 is a NA study that has completed, run by RAND. The registered enrollment target is 445 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (68% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05604508, a NA study, has completed, sponsored by RAND.
- COMPLETED
- Registry status
- NA
- Development phase
- 445 participants
- Enrollment target
Study Summary
The overall aim of this research is to experimentally evaluate different, legally-viable approaches to reducing the impact of the point-of-sale (POS) retail environment on adolescent tobacco use risk. This study will be investigating regulations for four classes of tobacco products (cigarettes, e-cigarettes, smokeless tobacco, little cigars/cigarillos). Study 2 and study 3 (out of 3 studies), occurring concurrently, will examine whether changing the number and content of posters on the outside doors at POS reduced adolescents' tobacco use risk.
Primary Outcome
Respondents answer the following items: "Do you think you will try a cigarette anytime soon?", "Do you think you will try a cigarette anytime in the next year?"; and "If one of your best friends offered you a cigarette, would you smoke it?". Responses are made on a 1 (Definitely not) to 10 (Definitely yes) scale and summed to produce a total smoking risk scale score (range from 3 - 30). Total scale scores are dichotomized: scores of 3 are coded as '0' (no risk) and any score greater than 3 is co
Interventions
- OTHER Many posters with prices
- OTHER Many posters, no prices
- OTHER Fewer posters, no price restrictions
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 445 participants |
| Start Date | 2022-10-12 |
| Est. Completion | 2024-03-07 |
| Phase | NA |
What the finished NCT05604508 record still lists
NCT05604508 is an interventional study that assigns participants to a tested intervention. The registered 445 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (68% lower).
The record links to 0 conditions, and to 3 interventions - of which Many posters with prices is the first listed.
NCT05604508 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05604508 about?
NCT05604508 is a clinical study titled "Testing Legally Feasible Options Studies 2/3". The overall aim of this research is to experimentally evaluate different, legally-viable approaches to reducing the impact of the point-of-sale (POS) retail environment on adolescent tobacco use risk. This study will be investigating regulations for four classes of tobacco products (cigarettes, e-ci...
What is the current status of trial NCT05604508?
This trial is currently completed. It is a NA study. The enrollment target is 445 participants. The study started on 2022-10-12. Estimated completion is 2024-03-07.
What interventions are being tested in trial NCT05604508?
The interventions under investigation include: Many posters with prices (OTHER), Many posters, no prices (OTHER), Fewer posters, no price restrictions (OTHER).
Who is sponsoring clinical trial NCT05604508?
This trial is sponsored by RAND, which has 78 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT05604508's enrollment target sits among peer trials
445 233rd of 2000 higher than 1,768 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01280994 · 445 participants · Phase 2
Hyperpolarized 129Xe MRI for Imaging Pulmonary Function
- NCT03504800 · 445 participants
OCT in Diagnosis of Irregular Corneas
- NCT04751435 · 445 participants · NA
Developing New Educational Materials About Genetic Testing for a Diverse Group of Cancer Patients
- NCT06348394 · 444 participants · NA
Intracardiac Versus Transesophageal Echocardiographic Guidance for Left Atrial Appendage Occlusion
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI